Targeted cancer therapies are drugs that block the growth and spread of cancer by interfering with specific molecules that are involved in the progression of cancer. They generally have less severe side effects compared with […]
KemPharm originally submitted a marketing application for Apadaz in 2016 but it was not approved by the FDA due to concerns over intranasal abuse. The company appealed the FDA’s decision and resubmitted a marketing application […]
Phosphodiesterase type 5 (PDE5) inhibitors are effective in erectile dysfunction (ED) but have several limitations, including a slow onset of action and long half-life. In a paper in the Journal of Sexual Medicine (online, 3 […]
Published in Science and conducted by researchers from the Royal Marsden and the Institute of Cancer Research, the study looked at whether mini-tumours could be used to predict how patients would respond to treatment. The […]
The firms will develop gene therapies containing vectors to deliver monoclonal antibodies directed against the tau protein, the accumulation of which leads to impaired brain function and neuronal cell loss. They aim to leverage […]